CME Sues CFTC Seeking Swap Classification for Kalshi Bitcoin Perps

The complaint centers on product classification under the Commodity Exchange Act. CME argues that perpetual contracts lack expiration dates and therefore operate as swaps subject to the institutional rulebook. CFTC approval of Kalshi's product on June 2026 opened retail access on a designated contract market. Primary filings show CME seeking declaratory relief rather than an outright ban.

CME's revenue model relies on repeated rolls of expiring futures contracts and associated clearing fees. Perpetual structures substitute funding rate payments for rolls, eliminating that recurring transaction flow. Exchange share prices declined after the Kalshi approval, reflecting investor assessment of lost volume. Comparable patterns appear in prior CFTC actions that expanded eligible products on DCMs.

The suit coincides with CFTC signals on Hyperliquid compliance pathways and broader efforts to bring offshore perpetual liquidity onshore. Kalshi's platform targets retail participants through simplified margin rules. Reclassification would shift oversight toward swap dealer registration and uncleared margin requirements, raising distribution costs.

Litigation timelines point to a CFTC motion to dismiss within 60 days. Parallel proceedings on prediction market classification may produce overlapping precedent on retail access limits. Regulators retain authority to impose leverage caps and disclosure standards regardless of final label.